Delivery Order 75N95024D00009-75N95025F00002
Award Date
9/29/25
Potential Completion Date
9/28/28
Potential Value
$56K
Federal Agency
National Institute on Drug Abuse
Awardee
Bachem Americas Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Torrance, CA 90505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a task order from the National Institute on Drug Abuse (NIDA), a civilian agency, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturing company. The task order is for a 3-year stability study extension on a current Good Manufacturing Practice (cGMP) batch of parathyroid hormone-related protein (PTH-IA). The total ceiling value of this firm fixed-price delivery order is $45,200.00. Bachem Americas Inc. has an existing Indefinite...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $827,789 firm fixed price delivery order against its CRO Support for NCATS Drug Substance Development and Manufacture master IDIQ contract to Bachem Americas, Inc. to support the manufacture of 1 kg of CGMP L-ENK in support of the Center's drug substance development and manufacture program. Performance will take place in Torrance, California over a four-year...
The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs....
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Enamine US Inc. for a pharmacokinetic study in mice compounds. The award amount is $14,550.00 and the period of performance ends on August 18, 2025. This contract was not set aside for any small business category. Enamine US Inc. is a for-profit organization that provides a range of chemical products and...
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH & CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
This federal contract award, with ID HHSN271201500024A, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $185,000.00 firm fixed-price purchase order was awarded to Enzo Life Sciences, Inc., a for-profit small disadvantaged business manufacturer of scientific and diagnostic research products. The contract is part of the SMALL MOLECULES FOR THE NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) major program,...
This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
This is a task order award under the National Institute on Drug Abuse's (NIDA) IDIQ contract No. HHSN271201800024I for receptor binding and predictive toxicology services. The award, valued at $291,884.01, was issued to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The task order is for work described under the NIDA contract with a period of performance from April 3, 2020 to April 2, 2021. The contract was awarded on a firm-fixed-price...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...